Cleveland Clinic Taussig Cancer Institute
Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.
ASCO® 2023 Insights: "EV-103 Dose Escalation/Cohort A - Long-Term Outcome of EV + Pembro in 1L Cisplatin-Ineligible Stage 3/4 UC With Nearly 4 Years of Follow-Up"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Shilpa Gupta
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Shilpa Gupta
Login to view comments.
Click here to Login
